Xios Therapeutics, Inc. — Form D
Xios Therapeutics, Inc. of Waltham, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-05. The offering totals $1.5M, of which $1.0M was reported sold. Industry: Other.
Offering
- Filed: 2018-07-05
- Form: D
- Accession: 0001662223-18-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.0M
- Remaining: $500K
- Investors: 21
- Date of first sale: 2018-06-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-316092
Issuer
- Name: Xios Therapeutics, Inc.
- CIK: 0001662223
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 100 Beaver Street, Waltham, MA, 02453
- Phone: 617-937-2300
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Jeff Bird | Director | Waltham, MA |
| Diala Ezzeddine | Director | Waltham, MA |
| Rick Wagner | Director | San Diego, CA |
| Diala Ezzeddine | Executive Officer | Waltham, MA |
Other filings by this issuer (1)
More